{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:24Z","timestamp":1789628544762,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Medicine and Health Science and Technology Project","award":["2021KY1191"],"award-info":[{"award-number":["2021KY1191"]}]},{"name":"National Oncology Clinical Key Speciality","award":["2023-GJZK-001"],"award-info":[{"award-number":["2023-GJZK-001"]}]},{"name":"Quzhou City Science and Technology Research Guiding Project","award":["2024ZD010"],"award-info":[{"award-number":["2024ZD010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10122-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:19:59Z","timestamp":1784305199000},"page":"5556-5574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Prognostic Model Based on Adipokine-Related Genes for Hepatocellular Carcinoma: Assessment of Patient Outcomes and Tumor Microenvironment Characterization"],"prefix":"10.1007","volume":"71","author":[{"given":"Jianwen","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"10122_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet 2022;400:1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4.","journal-title":"Lancet"},{"key":"10122_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1159\/000539349","volume":"33","author":"F Feng","year":"2024","unstructured":"Feng F, Zhao Y. Hepatocellular carcinoma: prevention, diagnosis, and treatment. Med Princ Pract 2024;33:414\u2013423. https:\/\/doi.org\/10.1159\/000539349.","journal-title":"Med Princ Pract"},{"key":"10122_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","volume":"31","author":"F Safri","year":"2024","unstructured":"Safri F, Nguyen R, Zerehpooshnesfchi S, George J, Qiao L. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Ther 2024;31:1105\u20131112. https:\/\/doi.org\/10.1038\/s41417-024-00764-w.","journal-title":"Cancer Gene Ther"},{"key":"10122_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"Gudivada IP, Amajala KC. Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment. Curr Genomics 2025;26:48\u201380. https:\/\/doi.org\/10.2174\/0113892029308243240709073945.","journal-title":"Curr Genomics"},{"key":"10122_CR5","doi-asserted-by":"publisher","first-page":"e18761429358008","DOI":"10.2174\/0118761429358008250305070518","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130\u20135p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1: miR-3130\u20135p enhances HCC growth via inhibiting FDX1. Curr Mol Pharmacol 2024;17:e18761429358008. https:\/\/doi.org\/10.2174\/0118761429358008250305070518.","journal-title":"Curr Mol Pharmacol"},{"key":"10122_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C et al. Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genomics 2024;25:2\u201311. https:\/\/doi.org\/10.2174\/0113892029273682240111052317.","journal-title":"Curr Genomics"},{"key":"10122_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye W, Wang J, Zheng J, Jiang M, Zhou Y, Wu Z. Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis. Protein Pept Lett 2024;31:706\u2013713. https:\/\/doi.org\/10.2174\/0109298665330781240830042601.","journal-title":"Protein Pept Lett"},{"key":"10122_CR8","doi-asserted-by":"publisher","first-page":"e92707","DOI":"10.7759\/cureus.92707","volume":"17","author":"KM Almazrouei","year":"2025","unstructured":"Almazrouei KM, Mishra V, Pandya H, Sambhav K, Bhavsar SN. Tumor microenvironment and its role in cancer progression: an integrative review. Cureus 2025;17:e92707. https:\/\/doi.org\/10.7759\/cureus.92707.","journal-title":"Cureus"},{"key":"10122_CR9","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 2021;320:C375\u2013C391. https:\/\/doi.org\/10.1152\/ajpcell.00379.2020.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10122_CR10","doi-asserted-by":"publisher","unstructured":"Pogodzinski D, Ostrowska L, Smarkusz-Zarzecka J, Zysk B (2022) Secretome of Adipose Tissue as the Key to Understanding the Endocrine Function of Adipose Tissue Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23042309","DOI":"10.3390\/ijms23042309"},{"key":"10122_CR11","doi-asserted-by":"publisher","first-page":"107327482513479","DOI":"10.1177\/10732748251347917","volume":"32","author":"X Ma","year":"2025","unstructured":"Ma X, Yang S, Li D. New insights into adipokines and the tumor microenvironment in breast cancer. Cancer Control 2025;32:10732748251347916. https:\/\/doi.org\/10.1177\/10732748251347917.","journal-title":"Cancer Control"},{"key":"10122_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol 2019;15:139\u2013154. https:\/\/doi.org\/10.1038\/s41574-018-0126-x.","journal-title":"Nat Rev Endocrinol"},{"key":"10122_CR13","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol 2024;17:e18761429310703. https:\/\/doi.org\/10.2174\/0118761429310703240823045808.","journal-title":"Curr Mol Pharmacol"},{"key":"10122_CR14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","volume":"22","author":"D Seyhan","year":"2025","unstructured":"Seyhan D, Allaire M, Fu Y et al. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy. Cell Mol Immunol 2025;22:1132\u20131158. https:\/\/doi.org\/10.1038\/s41423-025-01308-4.","journal-title":"Cell Mol Immunol"},{"key":"10122_CR15","first-page":"4028","volume":"12","author":"S Mukhopadhyay","year":"2022","unstructured":"Mukhopadhyay S, Tokumaru Y, Oshi M, Endo I, Yoshida K, Takabe K. Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival. Am J Cancer Res 2022;12:4028\u20134039.","journal-title":"Am J Cancer Res"},{"key":"10122_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther 2025;10:35. https:\/\/doi.org\/10.1038\/s41392-024-02075-w.","journal-title":"Signal Transduct Target Ther"},{"key":"10122_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41435-025-00333-7","volume":"26","author":"S Modak","year":"2025","unstructured":"Modak S, Aktar T, Majumder D, Singha AK, Maiti D. A systematic review on leptin\u2019s role in defining cancer: special emphasis on immunomodulation, inflammation, and therapeutic interventions. Genes Immun 2025;26:266\u2013286. https:\/\/doi.org\/10.1038\/s41435-025-00333-7.","journal-title":"Genes Immun"},{"key":"10122_CR18","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.62347\/PZDM1736","volume":"14","author":"P Hu","year":"2024","unstructured":"Hu P, Guo D, Cao K, Xu T. The role of novel adipokines in hepatocellular carcinoma progression: a mini review. Am J Cancer Res 2024;14:5471\u20135485. https:\/\/doi.org\/10.62347\/PZDM1736.","journal-title":"Am J Cancer Res"},{"key":"10122_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/hmbci-2014-0037","volume":"21","author":"A Booth","year":"2015","unstructured":"Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig 2015;21:57\u201374. https:\/\/doi.org\/10.1515\/hmbci-2014-0037.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10122_CR20","doi-asserted-by":"publisher","first-page":"3970605","DOI":"10.1155\/2017\/3970605","volume":"2017","author":"H Li","year":"2017","unstructured":"Li H, Bai E, Zhang Y, Jia Z, He S, Fu J. Role of nampt and visceral adiposity in esophagogastric junction adenocarcinoma. J Immunol Res 2017;2017:3970605. https:\/\/doi.org\/10.1155\/2017\/3970605.","journal-title":"J Immunol Res"},{"key":"10122_CR21","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ijc.25492","volume":"128","author":"HX Xu","year":"2011","unstructured":"Xu HX, Zhu XD, Zhuang PY et al. Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. Int J Cancer 2011;128:1559\u20131569. https:\/\/doi.org\/10.1002\/ijc.25492.","journal-title":"Int J Cancer"},{"key":"10122_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/abbs\/gmz134","volume":"52","author":"Z Liu","year":"2020","unstructured":"Liu Z, Chen M, Zhao R et al. CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai) 2020;52:18\u201325. https:\/\/doi.org\/10.1093\/abbs\/gmz134.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10122_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jhep.2012.09.032","volume":"58","author":"F Heindryckx","year":"2013","unstructured":"Heindryckx F, Coulon S, Terrie E et al. The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model. J Hepatol 2013;58:319\u2013328. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.032.","journal-title":"J Hepatol"},{"key":"10122_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jhep.2011.04.015","volume":"55","author":"G Alpini","year":"2011","unstructured":"Alpini G, Glaser SS, Zhang JP et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011;55:1339\u20131345. https:\/\/doi.org\/10.1016\/j.jhep.2011.04.015.","journal-title":"J Hepatol"},{"key":"10122_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer 2023;23:295\u2013316. https:\/\/doi.org\/10.1038\/s41568-023-00560-y.","journal-title":"Nat Rev Cancer"},{"key":"10122_CR26","doi-asserted-by":"publisher","first-page":"1475980","DOI":"10.3389\/fcell.2024.1475980","volume":"12","author":"S Fan","year":"2024","unstructured":"Fan S, Liu H, Hou J, Zheng G, Gu P, Liu X. Characterizing adipocytokine-related signatures for prognosis prediction in prostate cancer. Front Cell Dev Biol 2024;12:1475980. https:\/\/doi.org\/10.3389\/fcell.2024.1475980.","journal-title":"Front Cell Dev Biol"},{"key":"10122_CR27","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1097\/JS9.0000000000002632","volume":"111","author":"Y Hong","year":"2025","unstructured":"Hong Y, Li J, Qiu Y et al. Integrative in silico analysis of per- and polyfluorinated alkyl substances (PFAS)-associated molecular alterations in human cancers: a multi-cancer framework for predicting toxicogenomic disruption. Int J Surg 2025;111:5122\u20135136. https:\/\/doi.org\/10.1097\/JS9.0000000000002632.","journal-title":"Int J Surg"},{"key":"10122_CR28","doi-asserted-by":"publisher","first-page":"117311","DOI":"10.1016\/j.ecoenv.2024.117311","volume":"287","author":"H Song","year":"2024","unstructured":"Song H, Zhou H, Yang S, He C. Combining mendelian randomization analysis and network toxicology strategy to identify causality and underlying mechanisms of environmental pollutants with glioblastoma: a study of Methyl-4-hydroxybenzoate. Ecotoxicol Environ Saf 2024;287:117311. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117311.","journal-title":"Ecotoxicol Environ Saf"},{"key":"10122_CR29","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 2022;38:3844\u20133846. https:\/\/doi.org\/10.1093\/bioinformatics\/btac409.","journal-title":"Bioinformatics"},{"key":"10122_CR30","doi-asserted-by":"publisher","first-page":"1507845","DOI":"10.3389\/fimmu.2025.1507845","volume":"16","author":"RZ Wu","year":"2025","unstructured":"Wu RZ, Sun QQ, Fu Y et al. Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune response. Front Immunol 2025;16:1507845. https:\/\/doi.org\/10.3389\/fimmu.2025.1507845.","journal-title":"Front Immunol"},{"key":"10122_CR31","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.2147\/JIR.S442388","volume":"16","author":"H Shi","year":"2023","unstructured":"Shi H, Yuan X, Liu G, Fan W. Identifying and validating GSTM5 as an immunogenic gene in diabetic foot ulcer using bioinformatics and machine learning. J Inflamm Res 2023;16:6241\u20136256. https:\/\/doi.org\/10.2147\/JIR.S442388.","journal-title":"J Inflamm Res"},{"key":"10122_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12672-024-01388-0","volume":"15","author":"Y He","year":"2024","unstructured":"He Y, Li G, Wu Y et al. Actin like 6A is a prognostic biomarker and associated with immune cell infiltration in cancers. Discov Oncol 2024;15:503. https:\/\/doi.org\/10.1007\/s12672-024-01388-0.","journal-title":"Discov Oncol"},{"key":"10122_CR33","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","volume":"29","author":"J Ning","year":"2021","unstructured":"Ning J, Ye Y, Bu D et al. Imbalance of TGF-beta1\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther 2021;29:2067\u20132087. https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.016.","journal-title":"Mol Ther"},{"key":"10122_CR34","doi-asserted-by":"publisher","first-page":"114990","DOI":"10.1016\/j.bcp.2022.114990","volume":"199","author":"W Xu","year":"2022","unstructured":"Xu W, Cheng Y, Guo Y, Yao W, Qian H. Targeting tumor associated macrophages in hepatocellular carcinoma. Biochem Pharmacol 2022;199:114990. https:\/\/doi.org\/10.1016\/j.bcp.2022.114990.","journal-title":"Biochem Pharmacol"},{"key":"10122_CR35","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data Brief Bioinform 22. https:\/\/doi.org\/10.1093\/bib\/bbab260","DOI":"10.1093\/bib\/bbab260"},{"key":"10122_CR36","doi-asserted-by":"publisher","first-page":"174217","DOI":"10.1016\/j.ejphar.2021.174217","volume":"906","author":"MC Xiao","year":"2021","unstructured":"Xiao MC, Qian H, Huang CK et al. Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy. Eur J Pharmacol 2021;906:174217. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174217.","journal-title":"Eur J Pharmacol"},{"key":"10122_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/2211-5463.13052","volume":"11","author":"MM Shamaa","year":"2021","unstructured":"Shamaa MM. Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFkappaB, BCR\/ABL, and PI3K\/AKT signaling pathway-related proteins. FEBS Open Bio 2021;11:588\u2013597. https:\/\/doi.org\/10.1002\/2211-5463.13052.","journal-title":"FEBS Open Bio"},{"key":"10122_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.bjc.6605746","volume":"103","author":"AP Taylor","year":"2010","unstructured":"Taylor AP, Leon E, Goldenberg DM. Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1\/2 phosphorylation and cytoskeletal rearrangement. Br J Cancer 2010;103:82\u201389. https:\/\/doi.org\/10.1038\/sj.bjc.6605746.","journal-title":"Br J Cancer"},{"key":"10122_CR39","doi-asserted-by":"publisher","unstructured":"Stefani C, Miricescu D, Stanescu S, IIet al. (2021) Growth Factors, PI3K\/AKT\/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms221910260","DOI":"10.3390\/ijms221910260"},{"key":"10122_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"10122_CR41","doi-asserted-by":"publisher","first-page":"107646","DOI":"10.5306\/wjco.v16.i6.107646","volume":"16","author":"MH Peng","year":"2025","unstructured":"Peng MH, Zhang KL, Guan SW, Lin Q, Yu HB. Advances and challenges in pathomics for liver cancer: From diagnosis to prognostic stratification. World J Clin Oncol 2025;16:107646. https:\/\/doi.org\/10.5306\/wjco.v16.i6.107646.","journal-title":"World J Clin Oncol"},{"key":"10122_CR42","doi-asserted-by":"publisher","unstructured":"Kim JW, Kim JH, Lee YJ (2024) The Role of Adipokines in Tumor Progression and Its Association with Obesity Biomedicines 12. https:\/\/doi.org\/10.3390\/biomedicines12010097","DOI":"10.3390\/biomedicines12010097"},{"key":"10122_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41420-024-01995-4","volume":"10","author":"D Sun","year":"2024","unstructured":"Sun D, Li W, Ding D et al. IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway. Cell Death Discov 2024;10:230. https:\/\/doi.org\/10.1038\/s41420-024-01995-4.","journal-title":"Cell Death Discov"},{"key":"10122_CR44","first-page":"782","volume":"5","author":"Y Nong","year":"2015","unstructured":"Nong Y, Wu D, Lin Y, Zhang Y, Bai L, Tang H. Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-alpha-induced TNC expression promotes migration in HCC cells. Am J Cancer Res 2015;5:782\u2013791.","journal-title":"Am J Cancer Res"},{"key":"10122_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10142-025-01664-4","volume":"25","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C. SPP1 promotes malignant characteristics and drug resistance in hepatocellular carcinoma by activating fatty acid metabolic pathway. Funct Integr Genomics 2025;25:151. https:\/\/doi.org\/10.1007\/s10142-025-01664-4.","journal-title":"Funct Integr Genomics"},{"key":"10122_CR46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","volume":"32","author":"X Jin","year":"2025","unstructured":"Jin X, Lv Y, Bie F et al. METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death Differ 2025;32:466\u2013479. https:\/\/doi.org\/10.1038\/s41418-024-01406-2.","journal-title":"Cell Death Differ"},{"key":"10122_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12885-015-1990-6","volume":"16","author":"YP Vandewynckel","year":"2016","unstructured":"Vandewynckel YP, Laukens D, Devisscher L et al. Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma. BMC Cancer 2016;16:9. https:\/\/doi.org\/10.1186\/s12885-015-1990-6.","journal-title":"BMC Cancer"},{"key":"10122_CR48","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2022.2119353","volume":"19","author":"J Yao","year":"2023","unstructured":"Yao J, Tang S, Shi C et al. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1\/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma. Autophagy 2023;19:1221\u20131238. https:\/\/doi.org\/10.1080\/15548627.2022.2119353.","journal-title":"Autophagy"},{"key":"10122_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/tox.23059","volume":"36","author":"CL Yu","year":"2021","unstructured":"Yu CL, Yu YL, Yang SF et al. Praeruptorin A reduces metastasis of human hepatocellular carcinoma cells by targeting ERK\/MMP1 signaling pathway. Environ Toxicol 2021;36:540\u2013549. https:\/\/doi.org\/10.1002\/tox.23059.","journal-title":"Environ Toxicol"},{"key":"10122_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.15430\/JCP.2020.25.4.252","volume":"25","author":"H Zhang","year":"2020","unstructured":"Zhang H, Yi J, Yoon D, Ryoo Z, Lee I, Kim M. Imatinib and GNF-5 exhibit an inhibitory effect on growth of hepatocellar carcinoma cells by downregulating S-phase kinase-associated protein 2. J Cancer Prev 2020;25:252\u2013257. https:\/\/doi.org\/10.15430\/JCP.2020.25.4.252.","journal-title":"J Cancer Prev"},{"key":"10122_CR51","doi-asserted-by":"publisher","first-page":"854","DOI":"10.17179\/excli2025-8479","volume":"24","author":"J Fei","year":"2025","unstructured":"Fei J, Guo Y. MAPK\/ERK Signaling in tumorigenesis: mechanisms of growth, invasion, and angiogenesis. EXCLI J 2025;24:854\u2013879. https:\/\/doi.org\/10.17179\/excli2025-8479.","journal-title":"EXCLI J"},{"key":"10122_CR52","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A. The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology 2023;77:1773\u20131796. https:\/\/doi.org\/10.1002\/hep.32740.","journal-title":"Hepatology"},{"key":"10122_CR53","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.7150\/jca.35444","volume":"11","author":"G Liu","year":"2020","unstructured":"Liu G, Yin L, Ouyang X, Zeng K, Xiao Y, Li Y. M2 macrophages promote HCC cells invasion and migration via miR-149\u20135p\/MMP9 signaling. J Cancer 2020;11:1277\u20131287. https:\/\/doi.org\/10.7150\/jca.35444.","journal-title":"J Cancer"},{"key":"10122_CR54","doi-asserted-by":"publisher","first-page":"1581098","DOI":"10.3389\/fimmu.2025.1581098","volume":"16","author":"D Xie","year":"2025","unstructured":"Xie D, Liu Y, Xu F et al. Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances. Front Immunol 2025;16:1581098. https:\/\/doi.org\/10.3389\/fimmu.2025.1581098.","journal-title":"Front Immunol"},{"key":"10122_CR55","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00262-021-03076-2","volume":"71","author":"JN Guo","year":"2022","unstructured":"Guo JN, Chen D, Deng SH et al. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer. Cancer Immunol Immunother 2022;71:1313\u20131330. https:\/\/doi.org\/10.1007\/s00262-021-03076-2.","journal-title":"Cancer Immunol Immunother"},{"key":"10122_CR56","doi-asserted-by":"publisher","first-page":"100957","DOI":"10.1016\/j.tranon.2020.100957","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wang Z, Li F. Survival prediction and response to immune checkpoint inhibitors: a prognostic immune signature for hepatocellular carcinoma. Transl Oncol 2021;14:100957. https:\/\/doi.org\/10.1016\/j.tranon.2020.100957.","journal-title":"Transl Oncol"},{"key":"10122_CR57","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui E, Cheung J, Zhu J et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 2017;355:1428\u20131433. https:\/\/doi.org\/10.1126\/science.aaf1292.","journal-title":"Science"},{"key":"10122_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ol.2020.11880","volume":"20","author":"Y Yi","year":"2020","unstructured":"Yi Y, Ni XC, Liu G et al. Clinical significance of herpes virus entry mediator expression in hepatitis B virus-related hepatocellular carcinoma. Oncol Lett 2020;20:19. https:\/\/doi.org\/10.3892\/ol.2020.11880.","journal-title":"Oncol Lett"},{"key":"10122_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ebiom.2019.03.022","volume":"42","author":"J Long","year":"2019","unstructured":"Long J, Wang A, Bai Y et al. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine 2019;42:363\u2013374. https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.022.","journal-title":"EBioMedicine"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10122-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:08:05Z","timestamp":1789625285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10122"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10122-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}